請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/57712
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林靖愉(Ching-Yu Lin) | |
dc.contributor.author | Yee-Soon Ling | en |
dc.contributor.author | 林宜宋 | zh_TW |
dc.date.accessioned | 2021-06-16T06:59:24Z | - |
dc.date.available | 2014-10-09 | |
dc.date.copyright | 2014-10-09 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-07-17 | |
dc.identifier.citation | Chapter 1.
1. Z. Li, J. A. Mulholland, L. C. Romanoff, E. N. Pittman, D. A. Trinidad, M. D. Lewin and A. Sjodin, 2010, Assessment of non-occupational exposure to polycyclic aromatic hydrocarbons through personal air sampling and urinary biomonitoring, J. Environ. Monitor., 12, 1110-1118. 2. W. W. Nazaroff and B. C. Singer, 2003, Inhalation of hazardous air pollutants from environmental tobacco smoke in US residences, J. Expo. Anal. Environ. Epidemiol., 14, 71-77. 3. J. A. A. West, G. Pakehham, D. Morin, C. A. Fleschner, A. R. Buckpitt and C. G. Plopper, 2001, Inhaled naphthalene causes dose dependent Clara cell cytotoxicity in mice but not in rats, Toxicol Appl. Pharmacol., 173, 114-119. 4. IARC, IARC monographs on evaluation of carcinogenic risks to humans, Lyon, France, 2002. 5. NIOSH, Naphthalene http://www.cdc.gov/niosh/npg/npgd0439.html, 2014. 6. C. Y. Lin, M. A. Isbell, D. Morin, B. C. Boland, M. R. Salemi, W. T. Jewell, A. J. Weir, M. V. Fanucchi, G. L. Baker, C. G. Plopper and A. R. Buckpitt, 2005, Characterization of a Structurally Intact in Situ Lung Model and Comparison of Naphthalene Protein Adducts Generated in This Model vs Lung Microsomes, Chem. Res. Toxicol., 18, 802-813. 7. C. Y. Lin, Å. M. Wheelock, D. Morin, R. M. Baldwin, M. G. Lee, A. Taff, C. Plopper, A. Buckpitt and A. Rohde, 2009, Toxicity and metabolism of methylnaphthalenes: Comparison with naphthalene and 1-nitronaphthalene, Toxicology, 260, 16-27. 8. A. J. Phimister, M. G. Lee, D. Morin, A. R. Buckpitt and C. G. Plopper, 2004, Glutathione Depletion Is a Major Determinant of Inhaled Naphthalene Respiratory Toxicity and Naphthalene Metabolism in Mice, Toxicol. Sci., 82, 268-278. 9. C. G. Plopper, J. Macklin, S. J. Nishio, D. M. Hyde and A. R. Buckpitt, 1992, Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. III. Morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters, and rats after parenteral administration of naphthalene, Lab Invest, 67, 553-565. 10. C. G. Plopper, L. S. Van Winkle, M. V. Fanucchi, S. R. C. Malburg, S. J. Nishio, A. Chang and A. R. Buckpitt, 2001, Early Events in Naphthalene-Induced Acute Clara Cell Toxicity, Am. J. Respir. Cell Mol. Biol., 24, 272-281. 11. J. A. A. West, G. Pakehham, D. Morin, C. A. Fleschner, A. R. Buckpitt and C. G. Plopper, 2001, Inhaled Naphthalene Causes Dose Dependent Clara Cell Cytotoxicity in Mice but Not in Rats, Toxicol. Appl. Pharm., 173, 114-119. 12. P. H. Long, R. A. Herbert, J. C. Peckham, S. L. Grumbein, C. C. Shackelford and K. Abdo, 2003, Morphology of Nasal Lesions in F344/N Rats Following Chronic Inhalation Exposure to Naphthalene Vapors, Toxicol. Path., 31, 655-664. 13. S. G. M. Abdo, B. J. Chou, R. Herbert, K., 2001, Toxicity and carcinogenecity study in F344 rats following 2 years of whole body exposure to naphthalene vapors, Inhal. Toxicol, 13, 931-950. 14. R. M. Bruce, L. Haber and P. McClure, Toxicological review of naphthalene, Environmental Protection Agency, 1998. 15. K. Yatera, Y. Morimoto, H. Kim, HYamato, I. Tanaka and M. Kido, 2001, Increased expression of matrix metalloproteinase in Clara cell-ablated mice inhaling crystalline silica, Environ. Health Perspect., 109, 795-799. 16. C. G. Plopper, L. S. Van Winkle, M. V. Fanucchi, S. R. C. Malburg, S. J. Nishio, A. Chang and A. R. Buckpitt, 2001, Early events in naphthalene-induced acute Clara cell toxicity, Am J. Resp. Cell Mol., 24, 272-281. 17. C. G. Plopper, J. Macklin, S. J. Nishio, D. M. Hyde and A. R. Buckpitt, 1992, Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. III. Morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters, and rats after parenteral administration of naphthalene, Lab. Invest., 67, 553-565. 18. J. H. Hong, W. C. Lee, Y. M. Hsu, H. J. Liang, C. H. Wan, C. L. Chien and C. Y. Lin, 2013, Characterization of the biochemical effects of naphthalene on the mouse respiratory system using NMR-based metabolomics, J. Appl. Toxicol., In press DOI: 10.1002/jat.2970. 19. K. A. F. O'Brien, L. L. Smith and G. M. Cohen, 1985, Differences in naphthalene-induced toxicity in the mouse and rat, Chem. Biol. Interact., 55, 109-122. 20. T. M. Cho, R. L. Rose and E. Hodgson, 2006, In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes, Drug Metab. Dispos., 34, 176-183. 21. P. J. Vuchetich, D. Bagchi, M. Bagchi, E. A. Hassoun, L. Tang and S. J. Stohs, 1996, Naphthalene-induced oxidative stress in rats and the protective effects of vitamin E succinate, Free Radical Bio Med, 21, 577-590. 22. NTP, Toxicology and carcinogensis studies of naphthalene in B6C3F1 mice, Report Technical report series No. 410, U.S. deparment of health and human services, 1992. 23. L. S. Van Winkle, A. R. Buckpitt, S. J. Nishio, J. M. Isaac and C. G. Plopper, 1995, Cellular response in naphthalene-induced Clara cell injury and bronchiolar epithelial repair in mice, Am. J. Physiol. Lung Cell Mol. Physiol., 269, L800-L818. 24. C. G. Plopper, C. Suverkropp, D. Morin, S. Nishio and A. Buckpitt, 1992, Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene, J. Pharmacol. Exp. Ther., 261, 353-363. 25. L. S. Van Winkle, Z. A. Johnson, S. J. Nishio, C. D. Brown and C. G. Plopper, 1999, Early Events in Naphthalene-Induced Acute Clara Cell Toxicity, Am. J. Respir. Cell Mol. Biol., 21, 44-53. 26. J. A. A. West, G. Pakehham, D. Morin, C. A. Fleschner, A. R. Buckpitt and C. G. Plopper, 2001, Inhaled naphthalene causes dose dependent Clara cell cytotoxicity in mice but not in rats, Toxicol. Appl. Pharmacol., 173, 114-119. 27. S. J. Zacharek, C. M. Fillmore, A. N. Lau, D. W. Gludish, A. Chou, Joshua W. K. Ho, R. Zamponi, R. Gazit, C. Bock, N. Jäger, Z. D. Smith, T. M. Kim, A. H. Saunders, J. Wong, J. H. Lee, R. R. Roach, D. J. Rossi, A. Meissner, A. A. Gimelbrant, P. J. Park and C. F. Kim, 2011, Lung Stem Cell Self-Renewal Relies on BMI1-Dependent Control of Expression at Imprinted Loci, Cell Stem Cell, 9, 272-281. 28. B. A. Wong, 2007, Inhalation Exposure Systems: Design, Methods and Operation, Toxicologic Pathology, 35, 3-14. 29. A. Buckpitt, A. M. Chang, A. Weir, L. Van Winkle, X. Duan, R. Philpot and C. Plopper, 1995, Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters, Mol. Pharmacol, 47, 74-81. 30. A. Buckpitt, M. Buonarati, L. B. Avey, A. M. Chang, D. Morin and C. G. Plopper, 1992, Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey, J Pharmacol. Exp. Therap, 261, 364-372. 31. M. A. Shultz, D. Morin, A.-M. Chang and A. Buckpitt, 2001, Metabolic Capabilities of CYP2F2 with Various Pulmonary Toxicants and Its Relative Abundance in Mouse Lung Subcompartments, Journal of Pharmacology and Experimental Therapeutics, 296, 510-519. 32. C. H. Chichester, A. R. Buckpitt, A. Chang and C. G. Plopper, 1994, Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells, Mol. Pharmacol., 45, 664-672. 33. S. Kanekal, C. Plopper, D. Morin and A. Buckpitt, 1991, Metabolism and cytotoxicity of naphthalene oxide in the isolated perfused mouse lung, J. Pharmacol. Exp. Ther., 256, 391-401. 34. J. R. Oliver, R. Kushwah, J. Wu, E. Cutz, H. Yeger, T. K. Waddell and J. Hu, 2009, Gender differences in pulmonary regenerative response to naphthalene-induced bronchiolar epithelial cell injury, Cell Proliferat., 42, 672-687. 35. L. S. Van Winkle, A. D. Gunderson, J. A. Shimizu, G. L. Baker and C. D. Brown, 2002, Gender differences in naphthalene metabolism and naphthalene-induced acute lung injury, Am J. Physiol.- Lung C., 282, L1122-L1134. 36. R. Turkall, G. Skowronski, A. Kadry and M. Abdel-Rahman, 1994, A comparative study of the kinetics and bioavailability of pure and soil-adsorbed naphthalene in dermally exposed male rats, Arch. Environ. Contam. Toxicol., 26, 504-509. 37. J. V. Mackell, F. Rieders, H. Brieger and E. L. Bauer, 1951, Acute hemolytic anemia due to ingestion of naphthalne moth balls Pediatrics, 7, 722-728. 38. M. Doherty, G. Cohen and M. Smith, 1984, Mechanisms of toxic injury to isolated hepatocytes by 1-naphthol, Biochem Pharmacol, 33, 543-549. 39. G. J. Patti, O. Yanes and G. Siuzdak, 2012, Innovation: Metabolomics: the apogee of the omics trilogy, Nat. Rev. Mol. Cell. Biol., 13, 263-269. 40. A. Sreekumar, L. M. Poisson, T. M. Rajendiran, A. P. Khan, Q. Cao, J. Yu, B. Laxman, R. Mehra, R. J. Lonigro, Y. Li, M. K. Nyati, A. Ahsan, S. Kalyana-Sundaram, B. Han, X. Cao, J. Byun, G. S. Omenn, D. Ghosh, S. Pennathur, D. C. Alexander, A. Berger, J. R. Shuster, J. T. Wei, S. Varambally, C. Beecher and A. M. Chinnaiyan, 2009, Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression, Nature, 457, 910-914. 41. S. Fasulo, F. Iacono, T. Cappello, C. Corsaro, M. Maisano, A. D'Agata, A. Giannetto, E. De Domenico, V. Parrino, G. Lo Paro and A. Mauceri, 2012, Metabolomic investigation of Mytilus galloprovincialis (Lamarck 1819) caged in aquatic environments, Ecotox. Environ. Safe., 84, 139-146. 42. L. Zhang, X. Liu, L. You, D. Zhou, Q. Wang, F. Li, M. Cong, L. Li, J. Zhao, D. Liu, J. Yu and H. Wu, 2011, Benzo(a)pyrene-induced metabolic responses in Manila clam Ruditapes philippinarum by proton nuclear magnetic resonance (1H NMR) based metabolomics, Environ. Toxicol. Pharmacol., 32, 218-225. 43. X. Han, K. Yang and R. W. Gross, 2012, Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses, Mass Spectrom. Rev., 31, 134-178. 44. X. Han and R. W. Gross, 2005, Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples, Mass Spectrom. Rev., 24, 367-412. 45. M. Mapstone, A. K. Cheema, M. S. Fiandaca, X. Zhong, T. R. Mhyre, L. H. MacArthur, W. J. Hall, S. G. Fisher, D. R. Peterson, J. M. Haley, M. D. Nazar, S. A. Rich, D. J. Berlau, C. B. Peltz, M. T. Tan, C. H. Kawas and H. J. Federoff, 2014, Plasma phospholipids identify antecedent memory impairment in older adults, Nat Med, 20, 415-418. 46. C. Stegemann, R. Pechlaner, P. Willeit, S. R. Langley, M. Mangino, U. Mayr, C. Menni, A. Moayyeri, P. Santer, G. Rungger, T. D. Spector, J. Willeit, S. Kiechl and M. Mayr, 2014, Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study, Circulation, 129, 1821-1831. 47. E. Fahy, S. Subramaniam, H. A. Brown, C. K. Glass, A. H. Merrill, R. C. Murphy, C. R. H. Raetz, D. W. Russell, Y. Seyama, W. Shaw, T. Shimizu, F. Spener, G. van Meer, M. S. VanNieuwenhze, S. H. White, J. L. Witztum and E. A. Dennis, 2005, A comprehensive classification system for lipids, J. Lipid Res., 46, 839-862. 48. M. R. Gonzalez-Baró, T. M. Lewin and R. A. Coleman, 2007, Regulation of Triglyceride Metabolism II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin action, Journal Article, 292, G1195-G1199. 49. C. Michel and G. van Echten-Deckert, 1997, Conversion of dihydroceramide to ceramide occurs at the cytosolic face of the endoplasmic reticulum, FEBS Letters, 416, 153-155. 50. C. Bionda, J. Portoukalian, D. Schmitt, C. Rodriguez-Lafrasse and D. Ardail, 2004, Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria? , Biochem. J. , 382, 527-533. 51. C. P. Reynolds, B. J. Maurer and R. N. Kolesnick, 2004, Ceramide synthesis and metabolism as a target for cancer therapy, Cancer Letters, 206, 169-180. 52. B. K. Gillard, R. G. Clement and D. M. Marcus, 1998, Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways, Glycobiology, 8, 885-890. 53. C. Mencarelli and P. Martinez–Martinez, 2013, Ceramide function in the brain: when a slight tilt is enough, Cell. Mol. Life Sci., 70, 181-203. 54. V. Filippov, M. A. Song, K. Zhang, H. V. Vinters, S. Tung, W. M. Kirsch, J. Yang and P. J. Duerksen-Hughes, 2012, Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases, Journal of Alzheimer's disease : JAD, 29, 537-547. 55. N. F. Lamour and C. E. Chalfant, 2005, Ceramide-1-phosphate: the 'missing' link in eicosanoid biosynthesis and inflammation, Mol Interv., 5, 358-367. 56. J. Dong, X. Cai, L. Zhao, X. Xue, L. Zou, X. Zhang and X. Liang, 2010, Lysophosphatidylcholine profiling of plasma: discrimination of isomers and discovery of lung cancer biomarkers, Metabolomics, 6, 478-488. 57. Z. Li and D. E. Vance, 2008, Thematic Review Series: Glycerolipids. Phosphatidylcholine and choline homeostasis, J. Lipid Res., 49, 1187-1194. 58. T. Okazaki, T. Kondo, T. Kitano and M. Tashima, 1998, Diversity and complexity of ceramide signalling in apoptosis, Cellular Signalling, 10, 685-692. 59. A. Jana and K. Pahan, 2010, Sphingolipids in Multiple Sclerosis, Neuro. Mol. Med., 12, 351-361. 60. C. Tang, P. Tsao, C. Chen, M. Shiao, W.-H. Wang and C. Lin, 2011, Glycerophosphocholine molecular species profiling in the biological tissue using UPLC/MS/MS, J Chromatogr B, 879, 2095-2106. 61. M. Ståhlman, C. S. Ejsing, K. Tarasov, J. Perman, J. Borén and K. Ekroos, 2009, High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry, J. Chromatogr. B, 877, 2664-2672. 62. H. Nie, R. Liu, Y. Yang, Y. Bai, Y. Guan, D. Qian, T. Wang and H. Liu, 2010, Lipid profiling of rat peritoneal surface layers by online normal- and reversed-phase 2D LC QTOF-MS, J. Lipid Res., 51, 2833-2844. 63. J. M. Castro-Perez, J. Kamphorst, J. DeGroot, F. Lafeber, J. Goshawk, K. Yu, J. P. Shockcor, R. J. Vreeken and T. Hankemeier, 2010, Comprehensive LC−MSE lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients, J. Proteome Res., 9, 2377-2389. 64. D. G. McLaren, P. L. Miller, M. E. Lassman, J. M. Castro-Perez, B. K. Hubbard and T. P. Roddy, 2011, An ultraperformance liquid chromatography method for the normal-phase separation of lipids, Anal. Biochem., 414, 266-272. 65. M. Pulfer and R. C. Murphy, 2003, Electrospray mass spectrometry of phospholipids, Mass Sectrom.Rev., 22, 332-364. 66. A. Fauland, H. Köfeler, M. Trötzmüller, A. Knopf, J. Hartler, A. Eberl, C. Chitraju, E. Lankmayr and F. Spener, 2011, A comprehensive method for lipid profiling by liquid chromatography-ion cyclotron resonance mass spectrometry, J. Lipid Res., 52, 2314-2322. 67. P. Dugo, O. Favoino, R. Luppino, G. Dugo and L. Mondello, 2004, Comprehensive two-dimensional normal-phase (adsorption)−reversed-phase liquid chromatography, Anal. Chem., 76, 2525-2530. Chapter 2. 1. A. D. Watson, 2006, Thematic review series: Systems Biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems, J. Lipid Res., 47, 2101-2111. 2. M. Ståhlman, C. S. Ejsing, K. Tarasov, J. Perman, J. Borén and K. Ekroos, 2009, High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry, J. Chromatogr. B, 877, 2664-2672. 3. X. Han, K. Yang and R. W. Gross, 2012, Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses, Mass Sectrom.Rev., 31, 134-178. 4. H. Nie, R. Liu, Y. Yang, Y. Bai, Y. Guan, D. Qian, T. Wang and H. Liu, 2010, Lipid profiling of rat peritoneal surface layers by online normal- and reversed-phase 2D LC QTOF-MS, J. Lipid Res., 51, 2833-2844. 5. J. M. Castro-Perez, J. Kamphorst, J. DeGroot, F. Lafeber, J. Goshawk, K. Yu, J. P. Shockcor, R. J. Vreeken and T. Hankemeier, 2010, Comprehensive LC−MSE lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients, J. Proteome Res., 9, 2377-2389. 6. D. G. McLaren, P. L. Miller, M. E. Lassman, J. M. Castro-Perez, B. K. Hubbard and T. P. Roddy, 2011, An ultraperformance liquid chromatography method for the normal-phase separation of lipids, Anal. Biochem., 414, 266-272. 7. M. A. Henderson and J. S. McIndoe, 2006, Ionic liquids enable electrospray ionisation mass spectrometry in hexane, Chem. Commun., 2872-2874. 8. M. Pulfer and R. C. Murphy, 2003, Electrospray mass spectrometry of phospholipids, Mass Sectrom.Rev., 22, 332-364. 9. A. Fauland, H. Köfeler, M. Trötzmüller, A. Knopf, J. Hartler, A. Eberl, C. Chitraju, E. Lankmayr and F. Spener, 2011, A comprehensive method for lipid profiling by liquid chromatography-ion cyclotron resonance mass spectrometry, J. Lipid Res., 52, 2314-2322. 10. P. Dugo, O. Favoino, R. Luppino, G. Dugo and L. Mondello, 2004, Comprehensive two-dimensional normal-phase (adsorption)−reversed-phase liquid chromatography, Anal. Chem., 76, 2525-2530. 11. R. Taguchi and M. Ishikawa, 2010, Precise and global identification of phospholipid molecular species by an orbitrap mass spectrometer and automated search engine lipid search, J. Chromatogr. A, 1217, 4229-4239. 12. N. Navas-Iglesias, A. Carrasco-Pancorbo and L. Cuadros-Rodríguez, 2009, From lipids analysis towards lipidomics, a new challenge for the analytical chemistry of the 21st century. Part II: Analytical lipidomics, TRAC-Trend Anal. Chem., 28, 393-403. 13. H. Nygren, T. Seppanen-Laakso, S. Castillo, T. Hyotylainen and M. Oresic, 2011, Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues, Methods Mol. Biol, 708, 247-257. 14. J. Folch, M. Lees and G. H. S. Stanley, 1957, A simple method for the isolation and purification of total lipids from animal tissues., J. Biol. Chem., 226, 497-509. 15. C. Y. Lin, M. A. Isbell, D. Morin, B. C. Boland, M. R. Salemi, W. T. Jewell, A. J. Weir, M. V. Fanucchi, G. L. Baker, C. G. Plopper and A. R. Buckpitt, 2005, Characterization of a Structurally Intact in Situ Lung Model and Comparison of Naphthalene Protein Adducts Generated in This Model vs Lung Microsomes, Chem. Res. Toxicol., 18, 802-813. 16. H. C. Köfeler, A. Fauland, G. N. Rechberger and M. Trötzmüller, 2012, Mass spectrometry based lipidomics: An overview of technological platforms, Metabolites, 2, 19-38. 17. A. H. Merrill Jr, M. C. Sullards, J. C. Allegood, S. Kelly and E. Wang, 2005, Sphingolipidomics: High-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry, BBA - Molecular and Cell Biology of Lipids, 36, 207-224. 18. C. Tang, P. Tsao, C. Chen, M. Shiao, W. Wang and C. Lin, 2011, Glycerophosphocholine molecular species profiling in the biological tissue using UPLC/MS/MS, Journal of Chromatography B, 879, 2095-2106. 19. X. Han and R. W. Gross, 1995, Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry, Journal of the American Society for Mass Spectrometry, 6, 1202-1210 Chapter 3. 1. J.-H. Hong, W.-C. Lee, Y.-M. Hsu, H.-J. Liang, C.-H. Wan, C.-L. Chien and C.-Y. Lin, 2014, Characterization of the biochemical effects of naphthalene on the mouse respiratory system using NMR-based metabolomics, J. Appl. Toxicol., In press, DOI: 10.1002/jat.2970. 2. S. J. Zacharek, C. M. Fillmore, A. N. Lau, D. W. Gludish, A. Chou, Joshua W. K. Ho, R. Zamponi, R. Gazit, C. Bock, N. Jäger, Z. D. Smith, T. M. Kim, A. H. Saunders, J. Wong, J. H. Lee, R. R. Roach, D. J. Rossi, A. Meissner, A. A. Gimelbrant, P. J. Park and C. F. Kim, 2011, Lung Stem Cell Self-Renewal Relies on BMI1-Dependent Control of Expression at Imprinted Loci, Cell Stem Cell, 9, 272-281. 3. A. Giangreco, S. D. Reynolds and B. R. Stripp, 2002, Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction, Am. J. Pathol., 161, 173-182. 4. L. S. Van Winkle, A. R. Buckpitt, S. J. Nishio, J. M. Isaac and C. G. Plopper, 1995, Cellular response in naphthalene-induced Clara cell injury and bronchiolar epithelial repair in mice, Am. J. Physiol. Lung Cell Mol. Physiol., 269, L800-L818. 5. K. A. F. O'Brien, L. L. Smith and G. M. Cohen, 1985, Differences in naphthalene-induced toxicity in the mouse and rat, Chem. Biol. Interact., 55, 109-122. 6. C. G. Plopper, L. S. Van Winkle, M. V. Fanucchi, S. R. C. Malburg, S. J. Nishio, A. Chang and A. R. Buckpitt, 2001, Early Events in Naphthalene-Induced Acute Clara Cell Toxicity, Am. J. Respir. Cell Mol. Biol., 24, 272-281. 7. B. A. Wong, 2007, Inhalation Exposure Systems: Design, Methods and Operation, Toxicologic Pathology, 35, 3-14. 8. O. Beckonert, H. C. Keun, T. M. D. Ebbels, J. Bundy, E. Holmes, J. C. Lindon and J. K. Nicholson, 2007, Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts, Nat. Protocols, 2, 2692-2703. 9. J. Folch, M. Lees and G. H. S. Stanley, 1957, A simple method for the isolation and purification of total lipids from animal tissues., J. Biol.Chem., 226, 497-509. 10. M. Katajamaa, J. Miettinen and M. Orešič, 2006, MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data, Bioinformatics, 22, 634-636. 11. C. Y. Lin, H. Wu, R. Tjeerdema and M. Viant, 2007, Evaluation of metabolite extraction strategies from tissue samples using NMR metabolomics, Metabolomics, 3, 55-67. 12. Y. S. Ling, H. J. Liang, M. H. Lin, C. H. Tang, K. Y. Wu, M. L. Kuo and C. Y. Lin, 2014, Two-dimensional LC-MS/MS to enhance ceramide and phosphatidylcholine species profiling in mouse liver, Biomed. Chromatogr., In press DOI 10.1002/bmc.3162. 13. H. Nygren, T. Seppanen-Laakso, S. Castillo, T. Hyotylainen and M. Oresic, 2011, Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues, Methods Mol Biol., 708, 247-257. 14. C. M. Slupsky, K. N. Rankin, J. Wagner, H. Fu, D. Chang, A. M. Weljie, E. J. Saude, B. Lix, D. J. Adamko, S. Shah, R. Greiner, B. D. Sykes and T. J. Marrie, 2007, Investigations of the Effects of Gender, Diurnal Variation, and Age in Human Urinary Metabolomic Profiles, Anal. Chem., 79, 6995-7004. 15. J. Westerhuis, H. J. Hoefsloot, S. Smit, D. Vis, A. Smilde, E. J. Velzen, J. M. Duijnhoven and F. Dorsten, 2008, Assessment of PLSDA cross validation, Metabolomics, 4, 81-89. 16. L. Roberts, D. Hassall, D. Winegar, J. Haselden, A. Nicholls and J. Griffin, 2009, Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor δ from Peroxisome proliferator-activated receptor γ in the ob/ob mouse, Genome Med, 1, 1-12. 17. A. H. Merrill Jr, M. C. Sullards, J. C. Allegood, S. Kelly and E. Wang, 2005, Sphingolipidomics: High-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry, BBA - Molecular and Cell Biology of Lipids, 36, 207-224. 18. C. Tang, P. Tsao, C. Chen, M. Shiao, W. Wang and C. Lin, 2011, Glycerophosphocholine molecular species profiling in the biological tissue using UPLC/MS/MS, Journal of Chromatography B, 879, 2095-2106. 19. X. Han and R. W. Gross, 1995, Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry, Journal of the American Society for Mass Spectrometry, 6, 1202-1210. 20. R. H. Barton, J. K. Nicholson, P. Elliott and E. Holmes, 2008, High-throughput 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study, International Journal of Epidemiology, 37, i31-i40. 21. B. A. T. Willems, R. L. Melnick, M. C. Kohn and C. J. Portier, 2001, A physiologically based pharmacokinetic model for inhalation and intravenous administration of naphthalene in rats and mice, Toxicol. Appl. Pharmacol., 176, 81-91. 22. C. J. Waterfield, J. A. Turton, M. D. C. Scales and J. A. Timbrell, 1993, The correlation between urinary and liver taurine levels and between pre-dose urinary taurine and liver damage, Toxicology, 77, 1-5. 23. C. J. Waterfield, M. Mesquita, P. Parnham and J. A. Timbrell, 1993, Taurine protects against the cytotoxicity of hydrazine, 1,4-naphthoquinone and carbon tetrachloride in isolated rat hepatocytes, Biochem Pharmacol., 46, 589-595. 24. D. Michalk, P. Wingenfeld, C. Licht, T. Ugur and L. Siar, 1996, The mechanisms of taurine mediated protection against cell damage induced by hypoxia and reoxygenation, Adv. Exp. Med. Biol., 403, 223-232. 25. A. Buckpitt, A. M. Chang, A. Weir, L. Van Winkle, X. Duan, R. Philpot and C. Plopper, 1995, Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters, Mol. Pharmacol., 47, 74-81. 26. C. G. Plopper, C. Suverkropp, D. Morin, S. Nishio and A. Buckpitt, 1992, Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene, J. Pharmacol. Exp. Ther., 261, 353-363. 27. C. G. Plopper, L. S. Van Winkle, M. V. Fanucchi, S. R. C. Malburg, S. J. Nishio, A. Chang and A. R. Buckpitt, 2001, Early events in naphthalene-induced acute Clara cell toxicity, Am. J. Resp. Cell Mol., 24, 272-281. 28. C. Groussard, I. Morel, M. Chevanne, M. Monnier, J. Cillard and A. Delamarche, 2000, Free radical scavenging and antioxidant effects of lactate ion: an in vitro study, J. Appl. Physiol., 89, 169-175. 29. R. W. Scholz and R. M. Evans, 1977, Pulmonary fatty acid synthesis. II. Amino acids as fatty acid precursors in rat lung, Am. J. Physiol. Endocrinol Metab., 232, E364-369. 30. K. R. Messner and J. A. Imlay, 2002, Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase, J. Biol. Chem., 277, 42563-42571. 31. Y. F. Xu, O. Karmin and P. C. Choy, 1994, Plasmenylcholine (1-O-alk-1'-enyl-2-acyl-sn-glycero-3-phosphocholine) biosynthesis in guinea-pig heart and liver: cholinephosphotransferase is a bifunctional enzyme for the synthesis of phosphatidylcholine and plasmenylcholine, Biochem. J., 301, 131-137. 32. K. Gorgas, A. Teigler, D. Komljenovic and W. W. Just, 2006, The ether lipid-deficient mouse: Tracking down plasmalogen functions, Biochim. Biophys. Acta, Mol. Cell Res., 1763, 1511-1526. 33. J. Lessig and B. Fuchs, 2009, Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis, Curr. Med. Chem., 16, 2021-2041. 34. C. H. Tang, P. N. Tsao, C. Y. Lin, L. S. Fang, S. H. Lee and W. H. Wang, 2012, Phosphorylcholine-containing lipid molecular species profiling in biological tissue using a fast HPLC/QqQ-MS method, Anal. Bioanal. Chem., 404, 2949-2961. 35. B. Colsch, C. Afonso, I. Popa, J. Portoukalian, F. Fournier, J.-C. Tabet and N. Baumann, 2004, Characterization of the ceramide moieties of sphingoglycolipids from mouse brain by ESI-MS/MS: identification of ceramides containing sphingadienine, J. Lipid Res., 45, 281-286. 36. C. Mencarelli and P. Martinez–Martinez, 2013, Ceramide function in the brain: when a slight tilt is enough, Cell Mol.Life Sci., 70, 181-203. 37. L. Arana, P. Gangoiti, A. Ouro, M. Trueba and A. Gomez-Munoz, 2010, Ceramide and ceramide 1-phosphate in health and disease, Lipids Health Dis., 9, 15. 38. P. Fagone and S. Jackowski, 2009, Membrane phospholipid synthesis and endoplasmic reticulum function, J. Lipid Res., 50, S311-S316. 39. R. W. Hong, J. D. Rounds, W. S. Helton, M. K. Robinson and D. W. Wilmore, 1992, Glutamine preserves liver glutathione after lethal hepatic injury, Ann. Surg., 215, 114-119. 40. R. Kolesnick, 1994, Signal transduction through the sphingomyelin pathway, Mol. Chem. Neuropathol., 21, 287-297. 41. M. I. Pörn, M. P. Ares and J. P. Slotte, 1993, Degradation of plasma membrane phosphatidylcholine appears not to affect the cellular cholesterol distribution, J. Lipid Res., 34, 1385-1392. 42. A. C. Rustan and C. A. Drevon, in eLS, John Wiley & Sons, Ltd, 2001, DOI: 10.1038/npg.els.0003894. 43. S. Bagnasco, R. Balaban, H. M. Fales, Y. M. Yang and M. Burg, 1986, Predominant osmotically active organic solutes in rat and rabbit renal medullas, J. Biol. Chem. , 261, 5872-5877. 44. S. Kempson and M. Montrose, 2004, Osmotic regulation of renal betaine transport: transcription and beyond, Pflügers Archiv., 449, 227-234. 45. L. K. Cole, J. E. Vance and D. E. Vance, 2012, Phosphatidylcholine biosynthesis and lipoprotein metabolism, Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids, 1821, 754-761. 46. S. J. Stohs, S. Ohia and D. Bagchi, 2002, Naphthalene toxicity and antioxidant nutrients, Toxicology, 180, 97-105. 47. A. S. Wilson, C. D. Davis, D. P. Williams, A. R. Buckpitt, M. Pirmohamed and B. K. Park, 1996, Characterisation of the toxic metabolite(s) of naphthalene, Toxicology, 114, 233-242. 48. N. Khaselev and R. C. Murphy, 2000, Structural characterization of oxidized phospholipid products derived from arachidonate-containing plasmenyl glycerophosphocholine, J. Lipid Res., 41, 564-572. 49. J. A. A. West, G. Pakehham, D. Morin, C. A. Fleschner, A. R. Buckpitt and C. G. Plopper, 2001, Inhaled naphthalene causes dose dependent Clara cell cytotoxicity in mice but not in rats, Toxicol. Appl. Pharmacol., 173, 114-119. 50. L. S. Van Winkle, Z. A. Johnson, S. J. Nishio, C. D. Brown and C. G. Plopper, 1999, Early events in naphthalene-induced acute Clara Cell toxicity, Am. J. Respir. Cell Mol. Biol., 21, 44-53. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/57712 | - |
dc.description.abstract | 萘,為最常見的多環芳香烴類化合物,是一種普遍存在樟腦丸和石油產物中的環境污染物。過去,以核磁共振 (NMR) 為基礎的代謝體學研究結果顯示,小鼠經萘暴露後,一些親水性和疏水性代謝產物會受到其幹擾並產生影響。然而,核磁共振的低解析度限制了脂質等疏水性代謝物的結構辨識能力。因此,本研究開發以液相層析串聯質譜法 (LC-MS/MS) 為基礎的脂質體學方法平臺,並應用於分析萘暴露對不同器官脂質體造成的改變。為了探討在萘處理後不同器官中的脂質物種變化,以及對萘毒性可能之角色,我們開發了一套二維 (2D)液相層析系統,以提高脂質物種的分析。本研究所研發結合親水性交互作用(hydrophilic interaction liquid chromatography,HILIC)暨逆相之二維液相層析系統 (2D HILIC-RPLC) 可針對從生物檢體中所萃取出的神經醯胺(ceramide) 和磷脂醯膽鹼脂質 (phosphorylcholine-containing lipid) 做全面性的研究分析。本系統於第一階段利用Silica HILIC 層析管柱將脂質依種類進行分離,之後利用ACQUITY BEH C18 層析管柱針對同類脂質做進一步的分離。與傳統一維液相層析串聯質譜系統相比,本次開發之二維液相層析串聯質譜系統顯著降低基質效應,並且其偵測極限相對降低了二至三倍。我們證明本研究所建立的方法具有高精確度與再現性,統計結果顯示三個添加濃度之相對標準偏差小於百分之二十。新開發的系統可有效地應用在經過萘處理後實驗小鼠中的肺臟,肝臟與腎臟脂質體的分析。從化學計量學分析顯示,在小鼠中的肺臟和肝臟中磷脂醯膽鹼和神經醯胺量均有顯著改變,而腎臟只有磷脂醯膽鹼有變化。本研究結合以液相層析串聯質譜為基礎的脂質體學與以核磁共振為基礎的代謝體學方法平台分析萘在不同器官引發的變化。總結,小鼠暴露萘48 小時後,代謝體結果呈現,受傷的器官進行修復,在這個時間點脂質的變化與細胞膜修復機制有關。 | zh_TW |
dc.description.abstract | Naphthalene, a polycyclic aromatic hydrocarbon, a ubiquitous environmental pollutant present in mothballs and petroleum products, has the capability of causing illness in human. Previously, nuclear magnetic resonance (NMR)-based metabolomics revealed that several hydrophilic and hydrophobic metabolites were perturbed in mice after naphthalene treatments. However, low NMR resolution limited the identification of the hydrophobic metabolites including lipid. Therefore, in this study, liquid chromatography-tandem mass spectrometry- (LC-MS/MS) based focus lipidomics was applied to profile lipid species changes in various organs after naphthalene treatment. In order to profile the lipid species changes in various organs after naphthalene treatment, two-dimensional (2D) LC system has been developed to enhance the profiling of lipid species. Concisely, a 2D hydrophilic interaction liquid chromatography (HILIC) and reverse-phase (RP) liquid chromatography (LC) system coupled with triple-quadrupole mass spectrometry (MS) was developed to comprehensively profile ceramides and phosphorylcholine containing lipids in extracted biological samples. Developed 2D HILIC-RPLC system used a silica HILIC column operated in the first dimension to distinguish the lipid classes and a BEH C18 column operated in the second dimension to separate the lipid species of the same class. The regression linearity of each lipid was satisfactory in both systems; however,the absolute matrix effect factor was reduced in 2D LC-MS/MS system. Limits of detection of 2D LC-MS/MS system were 2-3-fold lower compared toone-dimensional (1D) RPLC-MS/MS. To summarize, developed method was proven to be accurate and producible, as relative standard deviations remained smaller than 20% at three spiked levels.The efficiency of this newly developed system was applied to profile lipidome in the lung, liver and kidney of mice after naphthalene treatment to understand the mechanisms of naphthalene induced toxicities. Chemometric analysis revealed that phosphorylcholine-containing lipids and ceramides were significantly altered in the lung and liver, whereas, only phosphatidylcholines (PCs) was observed in kidney. Elevated number of unsaturated bonds and fatty acyl chains in both ceramide and PCs were deemed to reduce cellular membrane rigidity and facilitating the trafficking of recovery elements into the cell for rejuvenation. Coupling the MS-based focus lipidomics and NMR-based metabolomics enabled the characterization of naphthalene-induced changes in various organs. As conclusion, 48 h after naphthalene treatment, the injured organs underwent rejuvenation and the lipids changes at this time points majorly responsible for the cellular rejuvenations. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T06:59:24Z (GMT). No. of bitstreams: 1 ntu-103-D97548026-1.pdf: 4668110 bytes, checksum: 2d081cc4ff38785f52c1006a331b08d8 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | Table of Contents
摘要 I Abstract II Thesis overview IV Table of Contents VI List of Figure VIII List of Tables XI Chapter 1 1 Introduction 1 1.1 Naphthalene introduction 1 1.2 Naphthalene: Mode of action 2 1.3 Experimental study on naphthalene 3 1.4 Naphthalene metabolisms and detoxification. 7 1.4 Metabolomics 9 1.5. Lipids and focus lipidomics 9 1.6 Sphingolipid: Ceramide and ceramide-1-phosphate. 16 1.7 Phosphorylcholine-containing lipid: Diacyl-phosphatidylcholine, plasmenylcholine, plasmanylcholine and sphingomyelin 17 1.8 Lipidomics practices 20 1.9 Lipidomic Coupling of LC system to MS 26 1.10 Purpose of this study. 27 1.11 References 28 Chapter 2 36 Two-dimensional LC-MS/MS to enhance ceramides and phosphorylcholine-containing lipids profiling 36 2.1 Introduction 36 2.2 Material and method 39 2.3 Results and discussion 54 2.4 Summary 59 2.5 References 60 Chapter 3 62 MS-based Lipidomics: Various Organ Responses Following Naphthalene Intervention 62 3.1 Introduction 62 3.2 Materials and methods 63 3.3 Results 68 3.4. Discussion 78 3.5 Summary of the toxicological effects of naphthalene 88 3.6 References 91 3.7 Supplementary information 96 Chapter 4 116 Conclusions 116 Chapter 5 117 Future work 117 Appendix 120 | |
dc.language.iso | en | |
dc.title | 以質譜技術為基礎的脂質體學研究小鼠經萘暴露後不同器官之效應 | zh_TW |
dc.title | The Mass Spectrometry-based Lipidomics to Study the Response of Various Organs in Mice after Naphthalene exposure | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 陳惠文(?Huei-Wen Chen) | |
dc.contributor.oralexamcommittee | 郭錦樺(Ching-Hua Kuo),唐川禾(Chuan-Ho Tang),吳焜裕(Kuen-Yuh Wu) | |
dc.subject.keyword | ?,代謝體,液相層析串聯質譜,磷脂醯膽鹼,神經醯胺, | zh_TW |
dc.subject.keyword | Naphthalene,Lipidomics,2D HILIC-RPLC system,ceramide,phosphorylcholine-containing lipids, | en |
dc.relation.page | 120 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-07-17 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 毒理學研究所 | zh_TW |
顯示於系所單位: | 毒理學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 4.56 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。